PDPN and neoplasm: On the other hand, the interaction between podoplanin on tumor cells and CLEC-2 on platelets is hopeful target for suppressing metastasis of podoplanin-positive tumors, because CLEC-2 null platelets show aggregation induced by physiological agonists such as thrombin, ADP, and collagen [86].